New combo tackles tough bladder cancer
Disease control
Completed
This early-phase study tested a combination of two drugs—avelumab (an immunotherapy) and docetaxel (a chemotherapy)—in 21 people with advanced bladder cancer that had stopped responding to standard platinum-based chemo or could not take it. The main goals were to find safe doses …
Phase: PHASE1 • Sponsor: Yousef Zakharia • Aim: Disease control
Last updated May 15, 2026 11:54 UTC